Description
| SKU: | RPCB2775 |
| Size: | 100 μg |
| Tag: | C-His |
| Reactivity: | SARS-COV-2 |
| Protein Description: | Recombinant SARS-COV-2 Nucleocapsid(B.1.1.529/Omicron) Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ser2- Ala419(P13L,E31del,R32del,S33del,R203K,G204R)) of sars-cov-2 N (B.1.1.529/Omicron) (Accession #QHD43423.2) fused with a 6×His tag at the C- terminus. |
| Endotoxin: | < 0.1 EU/μg of the protein by LAL method. |
| Purity: | ≥ 95 % as determined by SDS-PAGE. |
| Formulation: | Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0. |
| Gene ID: | 43740575 |
| Storage: | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
| Swiss-Prot: | QHD43423.2 |
 | Recombinant SARS-COV-2 Nucleocapsid(B. 1. 1.529/Omicron) Protein was determined by SDS- PAGE under reducing conditions with Coomassie Blue. |
 | Immobilized SARS-CoV-2 Envelope at 2 μg/mL (100 μL/well) can bind SARS-COV-2 Nucleocapsid with a linear range of 0. 2-65 ng/mL. |
